{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:17:10Z","timestamp":1789697830988,"version":"4.0.1"},"reference-count":31,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"abstract":"<jats:sec>\n                  <jats:title\/>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>BACKGROUND:<\/jats:title>\n                  <jats:p>The evidence is unclear about the optimal route of treatment for children with cellulitis, specifically how to assess the risk of moderate-to-severe cellulitis requiring intravenous (IV) antibiotics. We aimed to derive and validate a cellulitis risk assessment scoring system to guide providers as to which patients require IV antibiotics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>This was a prospective cohort study of children presenting to the emergency department aged 6 months to 18 years diagnosed with cellulitis from January 2014 to August 2017. Patients were divided into 2 groups based on route of antibiotics at 24 hours (the predetermined gold standard). Demographics and clinical features were compared. Clinicians were surveyed about which features they used to decide whether to start IV antibiotics. Combinations of differentiating features were plotted on receiver operating characteristic curves.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>There were 285 children in the derivation cohort used to create the Melbourne Area, Systemic features, Swelling, Eye, Tenderness (ASSET) Score, which has a maximum score of 7. The area under the curve was 0.86 (95% confidence interval 0.83\u20130.91). Using a cutoff score of 4 to start IV antibiotics yielded the highest correct classification of 80% of patients (sensitivity 60%; specificity 93%). This score was validated in 251 children and maintained a robust area under the curve of 0.83 (95% confidence interval 0.78\u20130.89).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>The Melbourne ASSET Score was derived and validated for cellulitis in children to guide clinicians regarding when to start IV antibiotics. Although intended for widespread use, if limitations exist in other settings, it is designed to allow for refinement and is amenable to local impact analysis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2018-1420","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T13:25:21Z","timestamp":1546521921000},"source":"Crossref","is-referenced-by-count":20,"title":["Development and Validation of a Cellulitis Risk Score: The Melbourne ASSET Score"],"prefix":"10.1542","volume":"143","author":[{"given":"Laila F.","family":"Ibrahim","sequence":"first","affiliation":[{"name":"Department of Paediatrics, University of Melbourne, Parkville, Australia; and"},{"name":"Murdoch Children\u2019s Research Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandy M.","family":"Hopper","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Melbourne, Parkville, Australia; and"},{"name":"Murdoch Children\u2019s Research Institute,"},{"name":"Emergency Department,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Donath","sequence":"additional","affiliation":[{"name":"Murdoch Children\u2019s Research Institute,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennett","family":"Salvin","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Melbourne, Parkville, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz E.","family":"Babl","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Melbourne, Parkville, Australia; and"},{"name":"Murdoch Children\u2019s Research Institute,"},{"name":"Emergency Department,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope A.","family":"Bryant","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University of Melbourne, Parkville, Australia; and"},{"name":"Murdoch Children\u2019s Research Institute,"},{"name":"Infectious Diseases Unit, Department of General Medicine, and"},{"name":"Hospital-In-The-Home Department, The Royal Children\u2019s Hospital, Parkville, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"issue":"2","key":"2021121012434466400_B1","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America [published correction appears in Clin Infect Dis. 2014;59:147\u2013159].","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2021121012434466400_B2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.annemergmed.2007.12.004","article-title":"Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.","volume":"51","author":"Pallin","year":"2008","journal-title":"Ann Emerg Med"},{"issue":"6","key":"2021121012434466400_B3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1086\/605434","article-title":"Epidemiology of dermatitis and skin infections in United States physicians\u2019 offices, 1993-2005.","volume":"49","author":"Pallin","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2021121012434466400_B4","doi-asserted-by":"crossref","first-page":"e20151223","DOI":"10.1542\/peds.2015-1223","article-title":"Decreasing duration of antibiotic prescribing for uncomplicated skin and soft tissue infections.","volume":"137","author":"Schuler","year":"2016","journal-title":"Pediatrics"},{"issue":"12","key":"2021121012434466400_B5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/emermed-2017-206829","article-title":"Evaluating an admission avoidance pathway for children in the emergency department: outpatient intravenous antibiotics for moderate\/severe cellulitis.","volume":"34","author":"Ibrahim","year":"2017","journal-title":"Emerg Med J"},{"issue":"4","key":"2021121012434466400_B6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1440-1754.2007.01236.x","article-title":"Prospective evaluation of the management of moderate to severe cellulitis with parenteral antibiotics at a paediatric day treatment centre.","volume":"44","author":"Gouin","year":"2008","journal-title":"J Paediatr Child Health"},{"issue":"10","key":"2021121012434466400_B7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/emj.2010.093443","article-title":"Ambulatory intravenous ceftriaxone in paediatric A&E: a useful alternative to hospital admission?","volume":"28","author":"Smith","year":"2011","journal-title":"Emerg Med J"},{"issue":"11","key":"2021121012434466400_B8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/PEC.0b013e31815a032f","article-title":"Management of cellulitis in a pediatric emergency department.","volume":"23","author":"Khangura","year":"2007","journal-title":"Pediatr Emerg Care"},{"issue":"3","key":"2021121012434466400_B9","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2012-0746","article-title":"Trends in resource utilization for hospitalized children with skin and soft tissue infections.","volume":"131","author":"Lopez","year":"2013","journal-title":"Pediatrics"},{"issue":"7","key":"2021121012434466400_B10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0196-0644(81)80236-3","article-title":"Cellulitis: initial management.","volume":"10","author":"Fleisher","year":"1981","journal-title":"Ann Emerg Med"},{"issue":"20","key":"2021121012434466400_B11","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.2017.5653","article-title":"Effect of cephalexin plus trimethoprim-sulfamethoxazole vs cephalexin alone on clinical cure of uncomplicated cellulitis: a randomized clinical trial.","volume":"317","author":"Moran","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"2021121012434466400_B12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/PEC.0b013e31816ecb43","article-title":"Predictors for admission of children with periorbital cellulitis presenting to the pediatric emergency department.","volume":"24","author":"Goldman","year":"2008","journal-title":"Pediatr Emerg Care"},{"issue":"5","key":"2021121012434466400_B13","first-page":"302","article-title":"Development of a clinical severity score for preseptal cellulitis in children.","volume":"19","author":"Vu","year":"2003","journal-title":"Pediatr Emerg Care"},{"key":"2021121012434466400_B14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijporl.2016.06.025","article-title":"Management of paediatric periorbital cellulitis: our experience of 243 children managed according to a standardised protocol 2012-2015.","volume":"87","author":"Crosbie","year":"2016","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"6","key":"2021121012434466400_B15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jaapos.2003.09.013","article-title":"Intracranial infection associated with preseptal and orbital cellulitis in the pediatric patient.","volume":"7","author":"Reynolds","year":"2003","journal-title":"J AAPOS"},{"issue":"2","key":"2021121012434466400_B16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/649793","article-title":"Hospital-acquired Staphylococcus aureus infections at Texas Children\u2019s Hospital, 2001-2007.","volume":"31","author":"Hult\u00e9n","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"2021121012434466400_B17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3201\/eid1601.090401","article-title":"Healthcare-associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom.","volume":"16","author":"Cunliffe","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"2021121012434466400_B18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archpedi.1978.02120300044008","article-title":"Nebulized racemic epinephrine by IPPB for the treatment of croup: a double-blind study.","volume":"132","author":"Westley","year":"1978","journal-title":"Am J Dis Child"},{"issue":"4","key":"2021121012434466400_B19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jpeds.2007.08.034","article-title":"The pediatric respiratory assessment measure: a valid clinical score for assessing acute asthma severity from toddlers to teenagers.","volume":"152","author":"Ducharme","year":"2008","journal-title":"J Pediatr"},{"issue":"6","key":"2021121012434466400_B20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1053\/jpsu.2002.32893","article-title":"Pediatric appendicitis score.","volume":"37","author":"Samuel","year":"2002","journal-title":"J Pediatr Surg"},{"issue":"4","key":"2021121012434466400_B21","doi-asserted-by":"crossref","first-page":"e20172699","DOI":"10.1542\/peds.2017-2699","article-title":"Development and validation of a novel Pediatric Appendicitis Risk Calculator (pARC).","volume":"141","author":"Kharbanda","year":"2018","journal-title":"Pediatrics"},{"issue":"10087","key":"2021121012434466400_B22","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/S0140-6736(17)30555-X","article-title":"Accuracy of PECARN, CATCH, and CHALICE head injury decision rules in children: a prospective cohort study.","volume":"389","author":"Babl","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"2021121012434466400_B23","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ajem.2010.04.018","article-title":"Using appendicitis scores in the pediatric ED.","volume":"29","author":"Mandeville","year":"2011","journal-title":"Am J Emerg Med"},{"issue":"1","key":"2021121012434466400_B24","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2014-3425","article-title":"Best practices for improving flow and care of pediatric patients in the emergency department.","volume":"135","author":"Barata","year":"2015","journal-title":"Pediatrics"},{"issue":"11","key":"2021121012434466400_B25","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1197\/j.aem.2007.06.039","article-title":"Implementation of clinical decision rules in the emergency department.","volume":"14","author":"Stiell","year":"2007","journal-title":"Acad Emerg Med"},{"issue":"2","key":"2021121012434466400_B26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"4","key":"2021121012434466400_B27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00006565-199708000-00003","article-title":"Using the hand to estimate the surface area of a burn in children.","volume":"13","author":"Nagel","year":"1997","journal-title":"Pediatr Emerg Care"},{"issue":"2","key":"2021121012434466400_B28","first-page":"118","article-title":"Validity of the mother\u2019s recall of her child\u2019s antibiotic use.","volume":"62","author":"Dasanayake","year":"1995","journal-title":"ASDC J Dent Child"},{"issue":"9","key":"2021121012434466400_B29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/heartjnl-2011-301247","article-title":"Risk prediction models: II. External validation, model updating, and impact assessment.","volume":"98","author":"Moons","year":"2012","journal-title":"Heart"},{"issue":"8","key":"2021121012434466400_B30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archpediatrics.2012.490","article-title":"Validation and refinement of a prediction rule to identify children at low risk for acute appendicitis.","volume":"166","author":"Kharbanda","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"2021121012434466400_B31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7326\/0003-4819-144-3-200602070-00009","article-title":"Translating clinical research into clinical practice: impact of using prediction rules to make decisions.","volume":"144","author":"Reilly","year":"2006","journal-title":"Ann Intern Med"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2018-1420\/1075995\/peds_20181420.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2018-1420\/1075995\/peds_20181420.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T01:16:05Z","timestamp":1639185365000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/143\/2\/e20181420\/76811\/Development-and-Validation-of-a-Cellulitis-Risk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,1]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,1]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2018-1420","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,1]]},"article-number":"e20181420"}}